Skip to main content
Back
Watch Compare

BIO KEY INTERNATIONAL INC

Data quality: 83%
BKYI
NASDAQ Technology Software
$0.57
▼ $0.01 (-1.50%)
Mkt Cap: 6.09 M
6 months return
—
Momentum
Neutral
ROE
-65.96%

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -3.35 M

Price History

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-65.96%
Below sector avg (1.58%)
ROIC-43.42%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio1.26
Interest Coverage-27.42

Valuation

PE (TTM)
-1.43
Below sector avg (-0.16)
P/B Ratio1.01
EV/EBITDAN/A
Dividend YieldN/A

Financial Trends

Peer Comparison

vs Technology sector median (1234 peers)
Metric Stock Sector Median
P/E -1.4 -0.2
P/B 1.0 3.0
ROE % -66.0 1.6
Net Margin % — -0.5
Rev Growth 5Y % — 7.3
D/E — 0.4

Analyst Price Target

1 analyst

Consensus from analysts covering this stock: typical price target vs today’s price, and how analysts rate it.

Strong Buy
Current
$0.57
+251.1%
Target
$2.00
$2.00
$2.00
$2.00
Forecast
Forward EPS $0.00
Est. Revenue 12.00 M

Earnings Estimates

Analyst forecasts for EPS and revenue by period. Annual = fiscal years; quarterly = near-term quarters. Figures are consensus (average of analyst estimates).

Period EPS Est. Revenue Est. Analysts
FY2026 $0.00
$0.00 – $0.00
12.00 M 1

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q32025 -$0.12 -$0.15 -23.8%
Q22025 -$0.15 -$0.20 -33.5%
Q12025 -$0.24 -$0.15 +39.5%
Q42024 -$0.35 -$0.53 -51.4%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -4.25 M
ROE -65.96% ROA -41.23%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -3.35 M
ROIC -43.42% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.26
Interest Coverage -27.42 Asset Turnover N/A
Working Capital 781,785 Tangible Book Value 5.16 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.43 Forward P/E N/A
P/B Ratio 1.01 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 0.51 Fwd Earnings Yield N/A
FCF Yield -55.04%
Market Cap 6.09 M Enterprise Value 4.05 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -0.31 OCF / Share -0.31
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 78.76%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -4.30 M -8.52 M -11.91 M -5.07 M -9.67 M
EPS (Diluted) — — — — —
Gross Profit 5.64 M 1.43 M 4.58 M 3.44 M 2.04 M
Operating Income -4.01 M -8.83 M -9.92 M -4.94 M -4.47 M
EBITDA — — — — —
R&D Expenses 2.51 M 2.39 M 3.25 M 2.36 M 1.40 M
SG&A Expenses 7.14 M 7.86 M 9.36 M 6.03 M 5.85 M
D&A 93,026.0 75,136.0 — — —
Interest Expense 175,755.0 218,270.0 10,462.0 18,000.0 4.34 M
Income Tax -22,998.0 -134,014.0 20,434.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 8.62 M 4.52 M 11.34 M 17.77 M 22.52 M
Total Liabilities 4.84 M 3.45 M 6.04 M 2.15 M 2.19 M
Shareholders' Equity 3.77 M 1.06 M 5.30 M 15.62 M 20.34 M
Total Debt 44,762.0 188,787.0 2.92 M 0.0 232,000.0
Cash & Equivalents 437,604.0 511,400.0 2.64 M 7.75 M 16.99 M
Current Assets 1.89 M 2.62 M 8.98 M 14.01 M 18.94 M
Current Liabilities 4.55 M 3.21 M 5.46 M 2.00 M 1.88 M